KRTAP9-L1 inhibitors represent a class of chemical compounds that target the specific function or interaction of the keratin-associated protein 9 locus 1 (KRTAP9-L1) gene product. The KRTAP9 family, in general, is involved in the structural composition and regulation of keratin, which forms an essential part of the cytoskeletal architecture in epithelial cells. By influencing the physical properties of keratin filaments, KRTAP9 proteins play a crucial role in maintaining the mechanical strength and flexibility of structures like hair, nails, and the outer layers of the skin. The inhibitors of KRTAP9-L1 are designed to interfere with these proteins' ability to properly interact with keratin, potentially altering the organization, assembly, or disassembly of keratin filaments. These interactions are highly specific, as the proteins of the KRTAP family are closely related, and inhibitors need to be designed to selectively bind or deactivate particular isoforms like KRTAP9-L1 without affecting others.
On a molecular level, KRTAP9-L1 inhibitors might function through a range of mechanisms. They could block binding sites necessary for protein-protein interactions, or they might alter the protein's conformation, preventing it from adopting the structural requirements needed for its biological function. These inhibitors may affect the electrostatic interactions or hydrophobic domains of KRTAP9-L1, which are essential for its stability and association with keratin filaments. The structural basis of KRTAP9-L1 and its inhibitors could involve a variety of chemical scaffolds, including small organic molecules or peptides, which interact with the protein's active or allosteric sites. This specificity is key, as any interference in KRTAP9-L1 functionality could lead to changes in the organization of keratin structures and thus significantly alter their mechanical properties. Understanding the detailed binding dynamics and structural modifications that KRTAP9-L1 inhibitors induce is crucial for elucidating their broader impact on keratin filament architecture.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, which can decrease overall protein levels, including KRTAP9-L1. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can increase protein levels by preventing degradation, potentially affecting KRTAP9-L1 stability. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Inhibits RNA polymerase, which can suppress RNA synthesis and potentially reduce KRTAP9-L1 expression. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Causes premature chain termination during protein translation, possibly reducing KRTAP9-L1 synthesis. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Inhibits lysosomal degradation pathways, which could affect the turnover of cellular proteins, including KRTAP9-L1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can decrease protein synthesis and also modulate autophagy, potentially impacting KRTAP9-L1 levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that can increase the levels of proteins, potentially influencing the stability of KRTAP9-L1. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
A potent inhibitor of RNA polymerase II, which can lead to decreased mRNA synthesis for many genes, possibly including KRTAP9-L1. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylases (HDACs), which can change chromatin structure and affect gene expression, potentially impacting KRTAP9-L1 expression. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
Binds to Hsp90 and inhibits its function, which can affect the stability and function of client proteins, potentially including KRTAP9-L1. | ||||||